These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 4752673

  • 1. Noroxyclothepin decanoate (VUFB-9976) long-acting neuroleptic drug.
    Kazdová E, Dlabac A.
    Act Nerv Super (Praha); 1973 May; 15(2):81-2. PubMed ID: 4752673
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-acting neuroleptics of perathiepin group: VUFB-9977 (oxyprothepin decanoate).
    Dlabac A, Kazdová E.
    Act Nerv Super (Praha); 1974 Aug; 16(3):166-7. PubMed ID: 4417411
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
    Dlabac A, Metys J, Metysová J.
    Act Nerv Super (Praha); 1971 Aug; 13(3):188-9. PubMed ID: 5113833
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Substitution of fluphenazine decanoate with oxyprothepine decanoate in long-term maintenance therapy in schizophrenia].
    David I, Filip V, Hellerová P.
    Cesk Psychiatr; 1986 Oct; 82(5):313-7. PubMed ID: 2878734
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical experience with octoclothepine in chronic mental patients.
    Uhlír F.
    Act Nerv Super (Praha); 1972 Oct; 14(2):90. PubMed ID: 5040176
    [No Abstract] [Full Text] [Related]

  • 15. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM.
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Depot fluphenazine enanthate and decanoate: comparative rates of release in dogs.
    Dreyfuss J, Ross JJ, Shaw JM, Miller I, Schreiber EC.
    J Pharm Pharmacol; 1975 Oct; 27(10):791-2. PubMed ID: 241800
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.